Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulseAugust 24, 2006Treating malignant tumours is difficult. Doctors have to destroy the tumour, but healthy tissue needs to be preserved. Chemotherapy tends to kill diseased cells, at the same time causing great damage to the body in general. So scientists are looking for ways to destroy only the rampant tumour cells. One way to achieve this is to transport substances inside of microcapsules into the tumour cells and release them there. Researchers led by André Skirtach and Gleb Sukhorukov at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, along with Wolfgang Parak at Ludwig-Maximilian-University in Munich, have now used a laser as a means of opening microcapsules inserted into a tumour cell. The capsules subsequently release their contents, a fluorescent test substance, into the cell. The scientists used a light microscope to monitor how the luminous materials distribute themselves within the cell. The vehicle that the researchers used was a polymer capsule only a few micrometres in diameter. The walls of the capsules were built from a number of layers of charged polymers, alternating positive and negative. In the laboratory, at least, this is an established way of producing transport containers for medicines, cosmetics, or nutrients, which can also pass through cell membranes. André Skirtach and his colleagues equipped the capsules with a kind of "open sesame". But it didn't require any magic-just nanoparticles made of gold or silver atoms. The scientists mixed together charged metal nanoparticles along with the polymers composing the walls of the vesicle. The tumour cells absorbed the microcapsules and then the scientists aimed an infrared laser at them. Metal nanoparticles are particularly good at absorbing the laser light and transmitting the heat further into their surroundings, heating up the walls. They became so hot that the bonds broke between the polymers and the shell and the capsules eventually opened. For the time being, the scientists have only been trying out their methods on isolated tumour cells. "In principle, however, active substances could be released into the body this way," says Helmuth Möhwald, director of the Max Planck Institute of Colloids and Interfaces, and one of the participating scientists. This has to (do) with the fact that infrared laser light can penetrate at least one centimetre deep into the tissue. The cells of the body heat up negligibly because laser light at this wavelength is insignificantly absorbed in the tissue. It is the metal particles in the walls of the microcapsules only that absorb the light-even when the microcapsules are in a cell, because the laser affects only them.
Besides using a "thermal opener", the scientists have found another way of making the capsules more stable. They simply heat up the newly created microcapsules very slightly, so that the diameter of the hollow capsules becomes smaller. At the same time, the molecules in their shell are located closer to each other, thickening the capsule walls and better protecting their contents. There is still, however, a major problem to solve before scientists can use this technology to create medicines which squeeze microcapsules into tumour cells. There is still no way to "steer" the microcapsules. Helmuth Möhwald says, "we have to add some kind of feature to the capsules so that they only recognise the target cells." Only these cells would then allow microcapsules through their membrane. Max Planck Society for the Advancement of Science Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Circadian Rhythms Genome Ear Infection Medical Imaging Erectile dysfunction Biomarkers Nicotine Dependence Acute Lymphoblastic Leukemia Brain Development Serotonin Genome Sequencing Curcumin DNA damage Bivalirudin Clostridium difficile Mortality Rate Behavior Invisibility Cloak Breastfeeding Large Hadron Collider Cardiac Death Glaucoma Fuel Cell Spinal Cord Injury Lymphedema
See More: Science News Tags | |||||||||||||||||||||
|
Related Tumour Current Events and Tumour News Articles New clue into how brain stem cells develop into cells which repair damaged tissue The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published today (01 July) in the journal Genes and Development. Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues Collaboration in prostate cancer translational research in Europe is not only vital to sustain the progress achieved in recent years but also to streamline current efforts between researchers and clinicians and avoid duplication or overlaps. Discovery of the cell's water gate may lead to new cancer drugs The flow of water into and out from the cell may play a crucial role in several types of cancer. Scientists at the University of Gothenburg have now found the gate that regulates the flow of water into yeast cells. 3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis Three new studies have individually shown the anti-TNF (tumour necrosis factor) therapy etanercept to be effective, with a good safety profile, in children under four years of age with juvenile idiopathic arthritis (JIA). Hormone therapy may confer more aggressive properties to prostate tumours Hormone therapy is often given to patients with advanced prostate cancer. Genetic pathway responsible for link between body clock disturbance and worsening arthritis The genes that regulate human circadian rhythm, or 'the body clock', are significantly disturbed in individuals with arthritis. An innovative surgical technique gives hope to patients suffering from refractory epilepsy Clinicians from the Centre hospitalier de l'Université de Montréal (CHUM) have perfected an operation, which was previously considered too dangerous, to control refractory insular epilepsy, using an innovative microsurgery technique. Breakthrough in radiotherapy promises targeted cancer treatment Current radiation therapy treatment damages a patient's healthy tissue as well as eradicating the tumour it is intended to destroy, making the treatment especially invasive and often causing nasty side effects. Key protein regulating inflammation may prove relevant to controlling sepsis Scientists at Singapore's Institute of Molecular and Cell Biology (IMCB), under the Agency for Science, Technology and Research (A*STAR), have identified the protein, WIP1, as the molecular "brake" that curbs severe inflammation in the body. Brain research shows past experience is invaluable for complex decision making Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that past experience really does help when we have to make complex decisions based on uncertain or confusing information. More Tumour Current Events and Tumour News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||